Biotech Shares Catch Premarket Bid On Tuesday
AllpennyStocks.com

Biotech Shares Catch Premarket Bid On Tuesday

By: Tomas Ronolski - AllPennyStocks.com News

Tuesday, March 21, 2023

A Massachusetts-based biotech company is finding early success on Tuesday after the company announced the Phase 3 DISSOLVE program of their SEL-212 in chronic refractory gout met the primary endpoint, according to the release.

While that is rather technical in nature, the bottom line is that traders are excited about the prospects of the announcement as shares of Selecta Biosciences (Nasdaq:SELB) are currently bid up at $1.38/share (+7.81% implied open for sellers) at the time of writing.

Selecta Biosciences Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. Its product pipeline includes MMA-101, SEL-212 for Chronic Severe Gout, SEL-313 for Ornithine Transcarbamylase Deficiency (OTC), and others.


Copyright © 2023 AllPennyStocks.com. All rights reserved. Republication or redistribution of AllPennyStocks.com's content is expressly prohibited without the prior written consent of AllPennyStocks.com. AllPennyStocks.com shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Other Penny Stock Movers

Shares of Dual-Listed Miner Up on News of Options on Uranium Properties
 Read More
Shares Up as Firm Launches First Short Spot Bitcoin ETP in the Nordics
 Read More
Could This Stock Be The Next Big Mover In The Short-Term Rental Market?
 Read More
Most Popular
1
Micro Cap Massively Bid Up Before Opening Bell
2
Could This Stock Be The Next Big Mover In The Short-Term Rental Market?
3
Dual Listed Biotech Firm Achieves Sale of Animal Health Interest, Sending Shares Higher
4
Dr. Martens shares lose a third of their value on U.S. warning
5
Gold to ‘shine bright like a diamond,’ hit $3,000 within months, says Citigroup
6
Shares of Dual-Listed Gold Miner Bid Up After Earnings Release
FREE Newsletter


Back to Top
Site Links:
Premium Services / Email Newsletter:
Social Media:
RSS Feed:
Partners:
© Copyright 2024 AllPennyStocks.com Media Inc. All rights reserved. Nasdaq Stocks: Information delayed 15 minutes. Non-Nasdaq Stocks: Information delayed 20 minutes.
Bid and Ask quotation information for NYSE and AMEX securities is only available on a real time basis. Data is provided by QuoteMedia.com.
© Copyright 1999 – 2024. AllPennyStocks.com Media Inc.
All rights reserved.